Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Ervebo® (Ebola Zaire Vaccine, Live) – New vaccine approval
December 19, 2019 - The FDA announced the approval of Merck’s Ervebo (Ebola Zaire Vaccine, Live), for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.
